Cargando…

Thromboembolism, Hypercoagulopathy, and Antiphospholipid Antibodies in Critically Ill Coronavirus Disease 2019 Patients: A Before and After Study of Enhanced Anticoagulation

To determine the prevalence of thrombotic events, functional coagulation tests, inflammatory biomarkers, and antiphospholipid antibodies before and after enhanced anticoagulation in critically ill coronavirus disease 2019 patients. DESIGN: Retrospective. SETTING: Tertiary intensive care unit. PATIEN...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Linden, Jan, Almskog, Lou, Liliequist, Andreas, Grip, Jonathan, Fux, Thomas, Rysz, Susanne, Ågren, Anna, Oldner, Anders, Ståhlberg, Marcus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Original Clinical Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752689/ https://www.ncbi.nlm.nih.gov/pubmed/33364605 http://dx.doi.org/10.1097/CCE.0000000000000308

Ejemplares similares

Prevalence and impact of chronic dysglycaemia among patients with COVID-19 in Swedish intensive care units: a multicentre, retrospective cohort study
por: Balintescu, Anca, et al.
Publicado: (2023)

Value of thromboelastography in managing hypercoagulopathy in intensive care
por: Aron, J, et al.
Publicado: (2015)

Screening of COVID-19-associated hypercoagulopathy using rotational thromboelastometry
por: Iwasaki, Yudai, et al.
Publicado: (2020)

Chinese expert consensus on diagnosis and treatment of trauma-induced hypercoagulopathy
por: Song, Jing-Chun, et al.
Publicado: (2021)

Direct oral anticoagulants in antiphospholipid syndrome with venous thromboembolism: Impact of the European Medicines Agency guidance
por: Fazili, Masarret, et al.
Publicado: (2019)

Thromboembolic Antiphospholipid Syndrome (APS): Efficacy and Safety of Different Anticoagulants-Results of the APSantiCO Registry
por: Schulz, Annabel, et al.
Publicado: (2022)

Recurrent life-threatening thromboembolism and catastrophic antiphospholipid syndrome in a patient despite sufficient oral anticoagulation
por: Miesbach, W., et al.
Publicado: (2004)

Rotational thromboelastometry results are associated with care level in COVID-19
por: Almskog, Lou M., et al.
Publicado: (2020)

A retrospective register study comparing fibrinogen treated trauma patients with an injury severity score matched control group
por: Almskog, Lou M., et al.
Publicado: (2020)

Anticoagulant Therapy in Patients with Antiphospholipid Syndrome
por: Capecchi, Marco, et al.
Publicado: (2022)

Inflammasome Activation-Induced Hypercoagulopathy: Impact on Cardiovascular Dysfunction Triggered in COVID-19 Patients
por: Gedefaw, Lealem, et al.
Publicado: (2021)

Hypercoagulopathy in Overweight and Obese COVID-19 Patients: a Single-Center Case Series
por: Sarfraz, Azza, et al.
Publicado: (2021)

Antiphospholipid antibodies and anticoagulant therapy: capillaroscopic findings
por: Ferrari, Giorgia, et al.
Publicado: (2021)

Laboratory Diagnosis of Antiphospholipid Syndrome in Anticoagulated Patients
por: Tripodi, Armando, et al.
Publicado: (2023)

Tissue Hypoperfusion, Hypercoagulopathy, and Kidney and Liver Dysfunction after Ingestion of a Naphazoline-Containing Antiseptic
por: Ono, Yuko, et al.
Publicado: (2017)

Hypercoagulopathy as a severe Long-term complication of post SARS-CoV-19 infection
por: Zhang, Xinhai R., et al.
Publicado: (2022)

Clinical Experience, Pathophysiology, and Considerations in the Prophylaxis and Treatment of Hypercoagulopathy of COVID-19: A Review Study
por: Pourafkari, Leili, et al.
Publicado: (2021)

Antiphospholipid Syndrome Secondary to Lupus Anticoagulant: Case Report for Clinical Anticoagulation Determination
por: Lambroussis, Constantino G, et al.
Publicado: (2022)

Hypercoagulation Detected by Rotational Thromboelastometry Predicts Mortality in COVID-19: A Risk Model Based on a Prospective Observational Study
por: Almskog, Lou M., et al.
Publicado: (2022)

Treatment with angiotensin II in COVID-19 patients may not be beneficial
por: Rysz, Susanne, et al.
Publicado: (2020)

Therapy with direct oral anticoagulants for secondary prevention of thromboembolic events in the antiphospholipid syndrome: a systematic review and meta-analysis of randomised trials
por: Adelhelm, Josefine B H, et al.
Publicado: (2023)

Hypercoagulopathy and Adipose Tissue Exacerbated Inflammation May Explain Higher Mortality in COVID-19 Patients With Obesity
por: Pasquarelli-do-Nascimento, Gabriel, et al.
Publicado: (2020)

Successful Anticoagulation Therapy for Antiphospholipid Syndrome with Mobile Aortic Thrombi
por: Park, Hyun Oh, et al.
Publicado: (2016)

Bilateral adrenal hemorrhage in antiphospholipid syndrome: Anticoagulation for the treatment of hemorrhage
por: Aldaajani, Hana, et al.
Publicado: (2018)

Adrenal Hemorrhage in a Patient Anticoagulated with Apixaban with Antiphospholipid Syndrome
por: Sanford, Zachary, et al.
Publicado: (2019)

Role of Direct Oral Anticoagulation Agents as Thromboprophylaxis in Antiphospholipid Syndrome
por: Arora, Shreya, et al.
Publicado: (2021)

O25 Catastrophic antiphospholipid crisis triggered by anticoagulant switch
por: Andev, Rajinder Singh, et al.
Publicado: (2021)

Nephrotic syndrome‐associated hypercoagulopathy is alleviated by both pioglitazone and glucocorticoid which target two different nuclear receptors
por: Waller, Amanda P., et al.
Publicado: (2020)

Serial rotational thromboelastography (ROTEM) in mechanically ventilated patients with COVID-19 demonstrates hypercoagulopathy despite therapeutic heparinization
por: Choi, James K, et al.
Publicado: (2022)

Prolonged fever and exaggerated hypercoagulopathy in malaria vivax relapse and COVID-19 co-infection: a case report
por: Asmarawati, Tri Pudy, et al.
Publicado: (2022)

Surviving critical COVID-19 requiring mechanical ventilation is associated with a high long-term risk of de novo arrhythmic events
por: Liliequist, A, et al.
Publicado: (2023)

Metabolomic Profile in Venous Thromboembolism (VTE)
por: Franczyk, Beata, et al.
Publicado: (2021)

Inflammation and hypercoagulopathy are predominant risk factors of severity in COVID-19 patients with diabetes mellitus: Summary of a meta-analysis
por: Dhar, Sujan K., et al.
Publicado: (2021)

Hypercoagulopathy in COVID-19, Deep Venous Thrombosis After Extra-Corporeal Membrane Oxygenation Therapy: A Case Report
por: Garg, Akash, et al.
Publicado: (2021)

THU035 Impact Of Surgery Or Medical Treatment With The Selective Glucocorticoid Receptor Modulator Relacorilant On Hypercoagulopathy In Patients With Cushing Syndrome
por: Simeoli, Chiara, et al.
Publicado: (2023)

Impact of vaccination status and anticoagulation on venous thromboembolism risk and outcomes in coronavirus disease 2019 patients
por: Volteas, Panagiotis, et al.
Publicado: (2023)

New anticoagulants for the prevention of venous thromboembolism
por: Becattini, Cecilia, et al.
Publicado: (2010)

New anticoagulants for the treatment of venous thromboembolism
por: Fernandes, Caio Julio Cesar dos Santos, et al.
Publicado: (2016)

Thromboembolism and anticoagulation after Fontan surgery
por: Viswanathan, Sangeetha
Publicado: (2016)

Extended anticoagulation for unprovoked venous thromboembolism
por: Castellucci, Lana A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2bq1eajkrouope2rdiduuftuak